Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 51407-876

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 51407-876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-876-60ol (Dalfampridine 10 mg)

Label for Dalfampridine 10 mg extended-release tablets by Golden State Medical Supply, Inc. The label includes the NDC 51407-876-60 and indicates a package count of 60 tablets. It provides medication guide information, storage instructions, and cautions about tablet handling and child safety.*

FDA Label Image

Dalfampridine-equa (Dalfampridine Equa)

A formula illustrating the calculation for creatinine clearance (Crcl), involving variables for age, weight (kg), serum creatinine (mg/dl), and the number 72. This is a clinical calculation formula, not a chemical structure.*

FDA Label Image

Dalfampridine-fig1 (Dalfampridine Fig1)

A bar chart comparing the percentage of patients achieving various thresholds of average percent increase in walking speed from baseline. Two groups are shown: placebo (N=72) with white bars, and Dalfampridine extended-release tablets 10 mg twice daily (N=224) with gray bars. The x-axis represents percent increase in walking speed (≥0% to ≥60%) and the y-axis shows the percentage of patients achieving these increases.*

FDA Label Image

Dalfampridine-fig2 (Dalfampridine Fig2)

A bar chart comparing the percentage of patients achieving various thresholds of average percent increase in walking speed from baseline. It displays data for two groups: placebo (N=118) and Dalfampridine extended-release tablets 10 mg twice daily (N=119). The x-axis shows percent increase categories ranging from 0% to 60%, and the y-axis shows the percentage of patients within each category.*

FDA Label Image

Dalfampridine-struc (Dalfampridine Struc)

Chemical structure of dalfampridine, showing a pyridine ring with an amino group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.